Castleark Management LLC Procept Bio Robotics Corp Transaction History

Castleark Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$56.31 - $84.99 $2.81 Million - $4.25 Million	-49,990 Reduced 53.61%	43,250 $3.46 Million
Q2 2024 Aug 13, 2024	BUY	$45.73 - $69.19 $1.63 Million - $2.47 Million	35,750 Added 62.18%	93,240 $5.7 Million
Q1 2024 May 15, 2024	BUY	$40.38 - $50.75 $2.32 Million - $2.92 Million	57,490 New	57,490 $2.84 Million
Q4 2022 Feb 09, 2023	BUY	$38.78 - $46.78 $41,106 - $49,586	1,060 Added 1.58%	67,960 $2.82 Million
Q3 2022 Nov 15, 2022	BUY	$30.9 - $50.65 $2.07 Million - $3.39 Million	66,900 New	66,900 $2.77 Million

295

41.6M

196K

141K

Ticker PRCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 44,592,300
Market Cap $2.66B
Description
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...

Get notified when there are updates to the investment portfolio of Castleark Management LLC, based on Form 13F filings with the SEC.

Stay updated on Castleark Management LLC with notifications on news.